Peripheral Arterial Disease (PAD) Pipeline Research Report 2024: Comprehensive Insights About 22+ Pipeline Drugs Featuring AdvanceCor, Novo Nordisk, Hemostemix, Helixmith, Aplagon, Vasa, IsomAb
21 nov. 2024 04h20 HE
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. "Peripheral Arterial...